MetaVia, Inc. (MTVA)
2.01
+0.05
(+2.55%)
USD |
NASDAQ |
Jun 11, 16:00
1.93
-0.08
(-3.98%)
After-Hours: 20:00
MetaVia SG&A Expense (Quarterly) : 1.924M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.924M |
| December 31, 2025 | 1.805M |
| September 30, 2025 | 1.561M |
| June 30, 2025 | 1.981M |
| March 31, 2025 | 1.559M |
| December 31, 2024 | 1.527M |
| September 30, 2024 | 1.742M |
| June 30, 2024 | 2.01M |
| March 31, 2024 | 1.977M |
| December 31, 2023 | 1.802M |
| September 30, 2023 | 1.601M |
| June 30, 2023 | 1.442M |
| March 31, 2023 | 1.883M |
| December 31, 2022 | 1.915M |
| September 30, 2022 | 2.533M |
| June 30, 2022 | 2.237M |
| March 31, 2022 | 1.955M |
| December 31, 2021 | 2.581M |
| September 30, 2021 | 2.07M |
| June 30, 2021 | 1.914M |
| March 31, 2021 | 2.187M |
| Date | Value |
|---|---|
| December 31, 2020 | 1.736M |
| September 30, 2020 | 1.795M |
| June 30, 2020 | 1.718M |
| March 31, 2020 | 2.597M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 2.495M |
| June 30, 2019 | 0.939M |
| March 31, 2019 | 0.651M |
| December 31, 2018 | 1.468M |
| September 30, 2018 | 2.364M |
| June 30, 2018 | 2.574M |
| March 31, 2018 | 2.087M |
| December 31, 2017 | 1.487M |
| September 30, 2017 | 2.05M |
| June 30, 2017 | 4.678M |
| March 31, 2017 | 2.223M |
| December 31, 2016 | 2.389M |
| September 30, 2016 | 1.466M |
| June 30, 2016 | 1.051M |
| March 31, 2016 | 1.05M |
| March 31, 2015 | 0.475M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 28.62M |
| UroGen Pharma Ltd. | 51.49M |
| Relay Therapeutics, Inc. | 11.03M |
| Aktis Oncology, Inc. | 5.897M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |